Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: Possible role of pegfilgrastim

Haematologica

Volumn 94, Issue 8, 2009, Pages 1175-1177

  Donadieu, Jean ^a   Beaupain, Blandine ^a   Rety Jacob, Frédérique ^b   Nove Josserand, Raphaelle ^b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b Hopital Sud   (France)

Author keywords

Adverse effects; Peg filgrastim; Severe chronic neutropenia

Indexed keywords

ANTIBIOTIC AGENT; DIURETIC AGENT; ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL PAIN; ANEMIA; ANTIBIOTIC THERAPY; BRONCHITIS; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; COLON RESECTION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE ASSOCIATION; DRUG SAFETY; ENTERITIS; ERYTHROCYTE TRANSFUSION; FEMALE; FLUID THERAPY; GLYCOGEN STORAGE DISEASE TYPE 1; GRAND MAL SEIZURE; HUMAN; HYPOGLYCEMIA; ILEOSTOMY; INFECTION SENSITIVITY; INTENSIVE CARE UNIT; INTERSTITIAL NEPHRITIS; KIDNEY DYSFUNCTION; LETTER; LEUKOCYTE COUNT; LIVER ADENOMA; METABOLIC ACIDOSIS; NEUTROPENIA; PERITONITIS; PNEUMONIA; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; SIDE EFFECT; SUDDEN DEATH; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; CHRONIC DISEASE; DEATH, SUDDEN; FATAL OUTCOME; FEMALE; FILGRASTIM; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; NEUTROPENIA; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 68049137476     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2008.005330     Document Type: Letter

References (10)

1. Dale DC, Bolyard AA, Schwinzer BG et al. The Severe Chronic Neutropenia International Registry: 10-year Follow-up Report. Support Cancer Ther 2006;3:220-31.
2. Donadieu J, Bader-Meunier B, Bertrand Y, Lachaux A, Labrune P, Gougerot-Pocidalo MA, et al. Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases. Nouv Rev Fr Hematol 1994;35:529-34.
3. Lyman GH, Kuderer NM. Filgrastim in patients with neutropenia: potential effects on quality of life. Drugs 2002;62 (Suppl 1):65-78.
4. Donadieu J, Barkaoui M, Bézard F, Bertrand Y, Pondarré C, Guibaud P. Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy. J Pediatr Hematol Oncol 2000;22:188-9.
5. Humbert M, Labrune P, Simonneau G. Severe pulmonary arterial hypertension in type 1 glycogen storage disease. Eur J Pediatr 2002;161 (Suppl 1):S93-S6.
6. Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K. Functional features of neutrophils induced by GCSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 1997;11:466-78.
7. Schilero GJ, Oropello J, Benjamin E. Impairment in gas exchange after granulocyte colony stimulating factor (GCSF) in a patient with the adult respiratory distress syndrome. Chest 1995;107:276-8.
8. Draper BK, Robbins JB, Stricklin GP. Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim. J Am Acad Dermatol 2005;52:901-5.
9. White LE, Villa MT, Petronic-Rosic V, Jiang J, Medenica MM. Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. Skinmed 2006;5:96-8.
10. Macartney C, Burke E, Elborn S, Magee N, Noone P, Gleadhill I, et al. Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim. Leuk Lymphoma 2005;46:1523-6.